Financhill
Sell
42

ROP Quote, Financials, Valuation and Earnings

Last price:
$449.12
Seasonality move :
8.12%
Day range:
$446.02 - $449.44
52-week range:
$435.42 - $595.17
Dividend yield:
0.73%
P/E ratio:
30.98x
P/S ratio:
6.30x
P/B ratio:
2.42x
Volume:
598.8K
Avg. volume:
1.1M
1-year change:
-14.4%
Market cap:
$48.4B
Revenue:
$7B
EPS (TTM):
$14.50

Earnings Data

Next earnings date for ROP
Jan 29
2026
Most recent earnings per share
$3.68
Missed by $1.43
(Oct 23/2025)
Consensus Estimate
$5.11
(Oct 23/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ROP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/29/2026 Q4 $2.1B -- -- $5.14 --
10/23/2025 Q3 $2B $2B $3.68 $5.11 -$1.43
07/21/2025 Q2 $1.9B $1.9B $3.49 $4.83 -$1.34
04/28/2025 Q1 $1.9B $1.9B $3.06 $4.74 -$1.68
01/30/2025 Q4 $1.8B $1.9B $4.28 $4.73 -$0.45
10/23/2024 Q3 $1.7B $1.8B $3.40 $4.53 -$1.13
07/24/2024 Q2 $1.7B $1.7B $3.12 $4.47 -$1.34
04/26/2024 Q1 $1.7B $1.7B $3.54 $4.34 -$0.80
01/31/2024 Q4 $1.6B $1.6B $3.51 $4.33 -$0.83
10/25/2023 Q3 $1.5B $1.6B $3.18 $4.22 -$1.04
07/21/2023 Q2 -- $1.5B $3.36 -- --
04/27/2023 Q1 -- $1.5B $2.65 -- --
01/27/2023 Q4 -- $1.4B $2.62 -- --
10/26/2022 Q3 -- $1.4B $3.05 -- --
07/22/2022 Q2 -- $1.3B $2.62 -- --
04/26/2022 Q1 -- $1.3B $2.84 -- --
02/02/2022 Q4 -- $1.3B $2.17 -- --
10/22/2021 Q3 -- $1.2B $2.71 -- --
07/23/2021 Q2 -- $1.2B $2.69 -- --
04/27/2021 Q1 -- $1.4B $2.73 -- --
01/29/2021 Q4 -- $1.3B $2.41 -- --
10/27/2020 Q3 -- $1.2B $2.21 -- --
07/28/2020 Q2 -- $1.3B $2.08 -- --
04/28/2020 Q1 -- $1.4B $2.28 -- --
01/30/2020 Q4 -- $1.4B $8.28 -- --
10/24/2019 Q3 -- $1.4B $2.64 -- --
07/25/2019 Q2 -- $1.3B $2.38 -- --
04/25/2019 Q1 -- $1.3B $3.53 -- --
02/01/2019 Q4 -- $1.4B $2.46 -- --
10/26/2018 Q3 -- $1.3B $2.37 -- --
07/26/2018 Q2 -- $1.3B $2.19 -- --
04/20/2018 Q1 -- $1.2B $2.03 -- --
02/02/2018 Q4 -- $1.2B $4.27 -- --
10/30/2017 Q3 -- $1.2B $1.84 -- --
07/31/2017 Q2 -- $1.1B $1.74 -- --
04/28/2017 Q1 -- $1.1B $1.53 -- --
02/09/2017 Q4 -- $1B $1.78 -- --
10/31/2016 Q3 -- $945.1M $1.63 -- --
07/25/2016 Q2 -- $931.6M $1.54 -- --
04/25/2016 Q1 -- $902.4M $1.48 -- --
02/01/2016 Q4 -- $943.6M $2.05 -- --

Roper Technologies, Inc. Earnings Questions

  • How Much did Roper Technologies, Inc. Generate in Revenue Last Quarter?

    Roper Technologies, Inc. reported $2B worth of top line sales in its most recent quarter.

  • Did Roper Technologies, Inc. Beat Earnings Last Quarter?

    Roper Technologies, Inc. announced earnings per share of $3.68 which represents a miss of analyst forecast a $5.11 per share.

  • Is Roper Technologies, Inc. Profitable?

    Roper Technologies, Inc. reported $1.4B that represents $12.94 per share over the last quarter.

  • What is the Analyst Consensus for Roper Technologies, Inc. EPS Next Year?

    Roper Technologies, Inc.'s earnings are forecast to grow from $14.35 per share to $18.25 per share next year representing an increase of 38.95%.

  • When is Roper Technologies, Inc.'s Earnings Date?

    Roper Technologies, Inc.'s next earnings date is January 29, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 3.24% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 1.39% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock